Computational Prediction of Viral Antigenic Evolution Using Phylogenetic and Structural Modeling

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-05-10

Key Takeaways

• Phylogenetic reconstruction, utilizing whole-genome sequencing and phylodynamic models, is fundamental for tracking viral lineages and identifying amino acid substitutions in surface glycoproteins (e.g., hemagglutinin and neuraminidase) associated with antigenic change in veterinary pathogens like avian influenza virus (AIV) and foot-and-mouth disease virus (FMDV).
• Selection pressure analyses, specifically the dN/dS ratio, are employed to pinpoint codons under positive selection within viral genes, often corresponding to known antibody-binding epitopes, thereby highlighting regions critical for antigenic drift in viruses such as H5N1 AIV.
• Three-dimensional structural modeling of viral glycoproteins, particularly the hemagglutinin head domain of influenza viruses and the spike protein of coronaviruses, allows for the precise mapping of mutations onto epitopes and the prediction of their impact on antibody recognition and viral escape.
• Machine learning approaches, including antigenic cartography and deep learning models, integrate sequence and structural data to predict antigenic variants and assess drift risk, enabling proactive vaccine strain selection for veterinary viruses.
• The integration of phylogenetic inference with structural epitope mapping and machine learning provides a powerful framework for predicting antigenic transitions and identifying emerging strains, crucial for timely vaccine updates and effective disease surveillance in veterinary medicine.
• Public databases such as GISAID for viral sequences and the Protein Data Bank for structural information are indispensable resources for these computational analyses, facilitating the development and validation of predictive models for veterinary pathogens.

Introduction

Antigenic evolution, the process by which surface glycoproteins of viruses accumulate mutations that alter epitope recognition by host antibodies, poses a persistent challenge to veterinary vaccine development and disease surveillance [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. In veterinary medicine, viruses such as avian influenza virus (AIV), infectious bronchitis virus (IBV), and foot-and-mouth disease virus (FMDV) undergo rapid antigenic drift that necessitates periodic vaccine strain updates [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>]. Computational methods that integrate phylogenetic analyses with structural modeling have emerged as essential tools for forecasting antigenic transitions and identifying emerging strains before they become epidemiologically dominant [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. This review provides a detailed examination of these computational approaches, emphasizing their application to veterinary pathogens and drawing on curated genomic and structural databases such as GISAID and the Protein Data Bank (PDB). The discussion is organized around phylogenetic inference, structural epitope modeling, and machine learning frameworks, with illustrative examples from influenza A viruses and coronaviruses in animal hosts.

Phylogenetic Methods for Tracking Antigenic Evolution

Phylogenetic reconstruction forms the backbone of antigenic evolution prediction by revealing the evolutionary relationships among circulating viral strains [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>]. For influenza A viruses in poultry and swine, whole-genome phylogenies allow the identification of lineages that carry amino acid substitutions in hemagglutinin (HA) and neuraminidase (NA) associated with antigenic change [<a href="#ref-9">9</a>]. The nomenclature system for seasonal influenza viruses, which tracks genetic clades and subclades, provides a standardized framework for veterinary surveillance [<a href="#ref-4">4</a>]. Phylodynamic models further estimate the tempo of antigenic drift by coupling phylogenetic trees with epidemiological data, enabling early detection of transitions between antigenic clusters [<a href="#ref-9">9</a>, <a href="#ref-10">10</a>].

Selection pressure analyses, particularly the ratio of nonsynonymous to synonymous substitution rates (dN/dS), are widely used to identify codons under positive selection in HA and NA genes [<a href="#ref-11">11</a>, <a href="#ref-12">12</a>]. For example, Tusche et al. applied a sliding-window approach to detect patches of positively selected sites in influenza A sequences, many of which correspond to known antibody-binding epitopes [<a href="#ref-11">11</a>]. Similarly, Zhai et al. employed mutational mapping to explore variation in dN/dS among sites and lineages, confirming that antigenic sites experience episodic diversifying selection [<a href="#ref-12">12</a>]. Duvvuri et al. demonstrated that positive selection in H5N1 HA clustered around the receptor-binding domain and exposed antigenic loops [<a href="#ref-13">13</a>]. These analyses are routinely incorporated into surveillance pipelines for AIV subtypes H5, H7, and H9 in avian hosts [<a href="#ref-14">14</a>, <a href="#ref-15">15</a>].

Beyond influenza, phylogenetic methods have been applied to IBV, a coronavirus of poultry. Ardicli et al. performed comprehensive phylogenetic characterization of IBV isolates from Uzbekistan, revealing the circulation of GI-1, GI-13, and GI-23 genotypes and emphasizing the need for genotype-matched vaccine strains [<a href="#ref-3">3</a>]. For FMDV, Reeve et al. developed sequence-based models that predict antigenic variability directly from phylogenetic distances and capsid protein sequence divergence, supporting vaccine strain selection in endemic regions [<a href="#ref-16">16</a>].

Structural Modeling of Epitopes

The three-dimensional structures of viral glycoproteins determine the accessibility and conformation of antibody epitopes [<a href="#ref-10">10</a>, <a href="#ref-17">17</a>]. For influenza A viruses, HA is the primary target of neutralizing antibodies, and its globular head domain contains five major antigenic sites (Sa, Sb, Ca1, Ca2, Cb for H1; A, B, C, D, E for H3) [<a href="#ref-1">1</a>, <a href="#ref-18">18</a>]. Mutations within these sites can abolish antibody binding without compromising receptor avidity, thereby driving antigenic drift [<a href="#ref-17">17</a>]. Structural modeling using homology modeling or deep learning methods (e.g., AlphaFold2, as described in the existing article on the AlphaFold Structure Prediction Server) allows the mapping of amino acid substitutions onto these epitopes and the prediction of their impact on antibody recognition [<a href="#ref-10">10</a>, <a href="#ref-19">19</a>].

Klein et al. demonstrated that HA stability, measured by the free energy of unfolding, correlates with evolutionary dynamics: strains with lower stability tend to be more antigenically divergent [<a href="#ref-17">17</a>]. This finding supports the use of thermodynamic calculations in predicting antigenic transitions. Neher et al. integrated structural information into a phenotypic model that predicts the antigenic distance between strains based on the location and physicochemical properties of HA mutations [<a href="#ref-10">10</a>]. The model successfully recapitulated the antigenic cluster transitions of H3N2 influenza in humans and can be adapted for veterinary subtypes.

For coronaviruses, the spike (S) protein contains the receptor-binding domain and multiple neutralizing epitopes. Norwood et al. developed the CoVerage platform, which combines genomic surveillance with structural mapping to predict the impact of mutations in SARS-CoV-2 S on antibody escape and ACE2 binding affinity [<a href="#ref-5">5</a>]. Although the study focused on a human pathogen, the methodology is directly transferable to animal coronaviruses such as IBV and porcine epidemic diarrhea virus (PEDV). Structural dynamics of coronavirus S protein are further explored in the companion article Structural and Evolutionary Dynamics of Coronavirus Spike Protein.

Epitope prediction algorithms that incorporate structural data have been validated for numerous veterinary viruses. Yang et al. predicted B-cell epitopes of H6N1 AIV HA using a combination of sequence conservation, solvent accessibility, and structural flexibility [<a href="#ref-20">20</a>]. Ren et al. developed a method for identifying conserved epitopes on influenza A HA that are targeted by broadly neutralizing antibodies, providing targets for universal vaccine design [<a href="#ref-19">19</a>]. For H5N1 highly pathogenic avian influenza, Qiu et al. used lineage-specific epitope profiling to guide pre-pandemic vaccine selection [<a href="#ref-21">21</a>].

Machine Learning Approaches

Machine learning has revolutionized antigenic evolution prediction by enabling the extraction of complex patterns from high-dimensional sequence and structural data [<a href="#ref-1">1</a>, <a href="#ref-22">22</a>]. Antigenic cartography, originally developed by Smith et al. (2004), uses multidimensional scaling to place viral strains in a two-dimensional antigenic map based on serological cross-reactivity data [<a href="#ref-10">10</a>]. This approach has been refined by Neher et al., who incorporated phylogenetic and structural information to visualize antigenic phenotypes of seasonal influenza viruses [<a href="#ref-10">10</a>]. For veterinary applications, similar maps have been constructed for AIV subtypes and FMDV serotypes [<a href="#ref-16">16</a>, <a href="#ref-22">22</a>].

Deep learning models have been applied to predict antigenic variants directly from sequence. Liao et al. trained support vector machines on HA1 sequence features to classify H3N2 antigenic variants [<a href="#ref-22">22</a>]. Lu et al. developed the PREDAV-H1 web server, which uses random forests to predict antigenic variants of H1N1 influenza based on HA mutations at key epitope positions [<a href="#ref-18">18</a>]. More recently, Agarwal et al. introduced multi-view transformers that simultaneously process sequence, structure, and co-occurrence information to score antigenic drift risk and identify mutation hotspots [<a href="#ref-1">1</a>]. This architecture incorporates attention mechanisms that capture long-range dependencies in glycan and protein interactions.

Association rule mining has been used to identify co-occurring mutations in HA and NA that are associated with antigenic escape [<a href="#ref-6">6</a>]. Galeone et al. applied this technique to large influenza sequence databases, revealing that certain combinations of mutations in HA epitopes and NA active site residues are significantly enriched in drift variants [<a href="#ref-6">6</a>]. These rules can be integrated into predictive models to flag emerging strains.

The integration of structural modeling with machine learning is exemplified by the computational pipeline for predicting vaccine escape mutations described in the existing article Predicting Vaccine Escape Mutations Using Structure-Based Deep Learning. By coupling deep mutational scanning with protein structure predictions, these approaches enable high-throughput assessment of antigenic consequences of individual substitutions.

The following diagram summarizes the typical workflow for computational prediction of viral antigenic evolution:

flowchart TD
 A["Viral Sequence Data (e.g., GISAID)"] --> B["Multiple Sequence Alignment"]
 B --> C["Phylogenetic Reconstruction"]
 B --> D["Selection Pressure Analysis (dN/dS)"]
 C --> E["Phylodynamic Modeling"]
 D --> E
 E --> F["Identify Candidate Mutations"]
 F --> G["Structural Modeling of Glycoprotein"]
 G --> H["Epitope Mapping"]
 H --> I["Calculate Antigenic Distance"]
 F --> J["Machine Learning Classifier"]
 J --> K["Predict Antigenic Cluster"]
 I --> K
 K --> L["Vaccine Strain Recommendation / Surveillance Alert"]

Integration of Phylogenetic and Structural Data

The most powerful computational frameworks combine phylogenetic and structural information in a unified model [<a href="#ref-2">2</a>, <a href="#ref-5">5</a>]. For example, Kimura et al. developed an integrative bioinformatics pipeline that correlates phylogenetic clade dynamics with structural changes in the HA receptor-binding site [<a href="#ref-2">2</a>]. By mapping mutations onto a rooted phylogeny and simultaneously projecting them onto the HA trimer structure, the pipeline identifies residues that both evolve rapidly and contact antibodies.

Castro et al. used a combination of phylogenetic tree shape metrics and structural distances to predict antigenic transitions for influenza A/H3N2 [<a href="#ref-9">9</a>]. Their model accurately forecasted the emergence of new dominant clusters up to one year in advance, relying on features such as branch length distribution and epitope mutation counts. This approach is adaptable to veterinary influenza viruses if sufficiently dense surveillance data are available.

For IBV, the integration is more challenging due to the high genetic diversity among genotypes. However, recent work by Ardicli et al. demonstrated that combining phylogenetic clustering with in silico epitope prediction can identify cross-protective epitopes shared among GI-1, GI-13, and GI-23 lineages [<a href="#ref-3">3</a>]. Such analyses support the development of broadly protective vaccines.

Data Sources and Computational Tools

Public databases are critical for these analyses. The Global Initiative on Sharing All Influenza Data (GISAID) provides the largest repository of influenza virus sequences and associated metadata, including host species and geographic origin (see the existing article on GISAID for further details). The Protein Data Bank (PDB) supplies experimentally determined three-dimensional structures of viral glycoproteins, with dedicated entries for HA (e.g., 4O5N for H5, 1RUZ for H3) and coronavirus S proteins (e.g., 6VSB for SARS-CoV-2 spike). A generic 3D protein viewer can be linked to these entries to illustrate structural changes in antigenic sites, such as the mutation-induced rotation of antibody-facing loops [<a href="#ref-1">1</a>, <a href="#ref-17">17</a>].

The role of computational biology in vaccine development is further elaborated in the article The Role of Computational Biology in COVID-19 Vaccine Development. Although that article focuses on a human pathogen, the methods are equally applicable to veterinary vaccine design.

Table 1. Selected computational methods for antigenic evolution prediction in veterinary viruses.

Challenges and Future Directions

Despite significant progress, several challenges remain. The availability of high-quality serological data for veterinary species is limited compared to human influenza, constraining the training of antigenic cartography and machine learning models [<a href="#ref-16">16</a>]. Many computational tools developed for human pathogens require adaptation to account for host-specific immune pressures and the diversity of domestic animal populations [<a href="#ref-2">2</a>, <a href="#ref-6">6</a>]. Additionally, the high mutation rate and reassortment potential of influenza A viruses necessitate continuous model updating [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>].

Future directions include the incorporation of glycan shield dynamics into structural models, as the glycan shield itself evolves and modulates epitope accessibility [<a href="#ref-1">1</a>]. The integration of deep mutational scanning data with computational predictions will improve accuracy for emerging variants [<a href="#ref-5">5</a>]. Finally, the development of user-friendly web servers (e.g., PREDAV-H1) that allow veterinary laboratories to perform real-time antigenic risk assessment without requiring extensive computational expertise will facilitate wider adoption [<a href="#ref-18">18</a>].

Conclusion

Computational prediction of viral antigenic evolution has matured into a multidisciplinary field that synergizes phylogenetics, structural biology, and machine learning. For veterinary virology, these tools enable proactive vaccine strain selection, surveillance of antigenic drift in economically important pathogens such as AIV and IBV, and improved understanding of host adaptation. Continued investment in data sharing and method validation across diverse animal host species will be essential for translating these computational advances into practical disease control interventions.

References

Related Clinical & Scientific Guides

• A Practical Guide to Detecting Antimicrobial Resistance Genes in Shotgun Metagenomic Data
• Computational Immunology: Modeling the Immune System
• How to Set Hard Filters for Germline Variant Calling: A Practical Guide to GATK Best Practices